Form 144 | Steris PLC(STE.US) Officer Proposes to Sell 707.85K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Steris PLC(STE.US)$ Officer Burton Karen L intends to sell 3,000 shares of its common stock on May 14, with a total market value of approximately $707.85K. Source:
Form 144 | Steris PLC(STE.US) Director Proposes to Sell 476.1K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Steris PLC(STE.US)$ Director Sohi Mohsen intends to sell 2,037 shares of its common stock on May 14, with a total market value of approximately $476.1K. Source: Ann
Form 144 | Steris PLC(STE.US) Officer Proposes to Sell 469.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Steris PLC(STE.US)$ Officer Majors Cary L intends to sell 2,024 shares of its common stock on May 13, with a total market value of approximately $469.84K. Source: A
Form 144 | Steris PLC(STE.US) Director Proposes to Sell 1.06 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Steris PLC(STE.US)$ Director KOSECOFF JACQUELINE B intends to sell 4,584 shares of its common stock on May 13, with a total market value of approximately $1.06 million
Unlocking Steris (STE) International Revenues: Trends, Surprises, and Prospects
Did you analyze how Steris (STE) fared in its international operations for the quarter ending March 2024? Given the widespread global presence of this medical products maker, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?
These large-cap stocks were the best performers in the last week. Are they in your portfolio?Teva Pharmaceutical Industries (NYSE:TEVA) shares surged 16.24% after the company reported mixed Q1 financi
Steris PLC Fiscal 2024 Earnings: Surpasses Revenue Forecasts and Adjusted EPS Expectations
STERIS Plc (NYSE:STE) Q4 2024 Earnings Call Transcript
Piper Sandler Reiterates Neutral on Steris, Raises Price Target to $225
Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Neutral and raises the price target from $220 to $225.
US bullish stocks this week | Electric power stocks are popular! Vistra and Constellation both recorded double-digit gains
Good performance boosts stock prices! AppLovin, International Fragrances and Fragrances, and Emerson Electric increased by 12.81%, 12.03%, and 8.49% respectively during the week.
KeyBanc Adjusts Price Target on STERIS to $255 From $253
STERIS (STE) has an average rating of outperform and price targets ranging from $215 to $265, according to analysts polled by Capital IQ.
Needham Reiterates Hold on Steris
Needham analyst Mike Matson reiterates Steris with a Hold.
Q4 2024 STERIS Plc Earnings Call
J.P. Morgan Securities: Reiterated the Steris (STE.US) rating and adjusted from superior to superior market rating, with a target price of $265.00.
J.P. Morgan Securities: Reiterated the Steris (STE.US) rating and adjusted from superior to superior market rating, with a target price of $265.00.
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
JMP Securities analyst David Turkaly reiterates Steris with a Market Outperform and maintains $265 price target.
Steris Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 18.71% JMP Securities → $265 Reiterates Market Outperform → Market Outperform 04/12/2024 — Need
Earnings Call Summary | Steris PLC(STE.US) Q4 2024 Earnings Conference
The following is a summary of the STERIS Plc (STE) Q4 2024 Earnings Call Transcript:Financial Performance:STERIS Plc reported total Q4 revenue growth of 10%, with adjusted earnings per diluted share a
STERIS Plc (STE) Q4 2024 Earnings Call Transcript
STERIS plc (STE) Q4 2024 Earnings Call Transcript
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
STERIS plc STE reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.41, up 4.8% from the year-ago quarter's figure.
STERIS Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results. The Company Announced Planned Restructuring of Its Healthcare Surgical Business in Europe.
STERIS Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results. The Company Announced Planned Restructuring of Its Healthcare Surgical Business in Europe.
No Data